Objective: To determine the effect of hyperinsulinemia on food intake and plasma concentrations of glucose and food intake regulatory hormones in men after a glucose drink. Design: Cross-sectional clinical intervention study of the effect of a glucose drink on food intake regulation. Subjects: Thirty-three normoinsulinemic (NI) (body mass index (BMI) ¼ 25.370.6; age ¼ 41.472.4) and 32 hyperinsulinemic (HI) men (BMI ¼ 29.570.6; age ¼ 43.472.6). Measurements: Food intake was measured from a pizza meal 1 h after subjects consumed either a noncaloric sweetened drink or a glucose-containing drink (75g/300 ml) in random order on two occasions. On another occasion, blood samples were taken every 30 min for 2 h after the glucose drink. Results: Fasting insulin in the HI and NI men was 6573 (mean7s.e.m.) and 2671.5 pmol/l, respectively. Food intake at the pizza meal was reduced by the glucose drink (Po0.01), but more so in HI (À9.774.1 %) than NI men (À5.473.4 %) (P ¼ 0.06). The increase in plasma insulin and cholecystokinin (CCK) after the glucose drink was greater and the plasma concentrations of leptin were higher, and ghrelin and adiponectin were lower in HI men than in NI men (Po0.05). Conclusion: These results support epidemiological data suggesting that hyperinsulinemia, at least in the early stages, may provide resistance to weight gain, possibly through physiological mechanisms of food intake control.
Introduction
Overfeeding and weight gain cause hyperinsulinemia. 1 Elevated fasting plasma insulin has been associated with increased weight gain in Pima Indian children, 2 suggesting that hyperinsulinemia promotes increased energy intake. However, longitudinal studies of adults from several ethnic groups report that hyperinsulinemic (HI) or insulinresistance subjects gain less weight than insulin-sensitive subjects, [3] [4] [5] [6] implying better intake control relative to expenditure. Recently, it has been proposed that 'the development of insulin resistance/hyperinsulinemia promotes the occurrence of the metabolic syndrome but also favors over time the re-equilibration of energy intake and expenditure'. 7 An association between elevated fasting insulin and equilibrium between energy intake and expenditure would be expected from the role of insulin in the brain as a central regulator of food intake. 8 During hyperinsulinemia and with stable glycemia, insulin concentrations are increased in brain areas involved in suppression of food intake and the regulation of energy homeostasis. 9 Centrally, insulin reduces the gene expression of neuropeptide Y (NPY), 10 a neuropeptide with orexigenic effects, and stimulates proopiomelanocortin (POMC), a precursor molecule with anorexigenic effects. 11 In addition, insulin stimulates leptin mRNA expression 12 and increases leptin concentrations even in physiological amounts. 13 Furthermore, hyperinsulinemia in men with normal glucose tolerance has been associated with reduced fasting ghrelin, 14 an orexigenic hormone.
Because insulin resistance and type 2 diabetes are preceded by hyperinsulinemia and obesity is associated with hyperinsulinemia, it may be that hyperinsulinemia creates a protective-adaptive response in food intake mechanisms, thereby contributing to weight stability. This hypothesis has not been explored. In normoinsulinemic (NI) individuals, appetite and food intake are inversely related to blood concentrations of glucose, [15] [16] [17] insulin, 8 leptin 18 and gastrointestinal hormones including cholecystokinin (CCK) 19 immediately following carbohydrate consumption.
However, the effect of hyperinsulinemia in the presence of normal glycemia on short-term food intake and satiety hormones after carbohydrate consumption has not been reported. Therefore, we examined data derived from a study originally designed to determine the effect of insoluble cereal fiber consumption on plasma glucose and insulin responses in HI and NI men. 20 
Materials and methods
Subjects Seventy-eight healthy men aged 18-75 years, with a body mass index (BMI) of 20-35 kg/m 2 were recruited, as described previously. 20 Sixty-five men were eligible. Subjects were screened with a fasting blood sample for glucose, insulin, lipids, and had their weight, height and waist circumference measured. They were excluded if they had diabetes (fasting glucose X7.0 mmol/l), impaired liver enzyme (aspartate aminotransferase (AST) 42 times upper limit of normal), impaired renal function (serum creatinine 41.2 times upper limit of normal), serum triacylglycerol 410 mmol/l (interferes with measurement of glucose/insulin), were taking diuretics, b-blockers or weight reducing agents, had a major gastrointestinal disease (e.g. ulcerative colitis), motility disorder or malabsorption, liver or kidney disease or have had a major medical or surgical event within the last 6 months. The subjects who ate o600 kcal of test pizza after the control preload were excluded from the data analysis on the assumption that they did not like pizza and therefore restricted their intake. Unfortunately, in this study, subjects were not asked whether they liked pizza. An intake of 600 kcal is below the normal range (mean72 s.d.) of pizza consumption found in previous studies when subjects were asked if they liked pizza. Sample size calculation to identify a 150 kcal response to the treatment was based on an intake average of 1000 kcal. [15] [16] [17] Subjects were classified into two groups: 32 HI and 33 NI. Subjects were classified as HI if their fasting plasma insulin was X41 pmol/l and as NI if their fasting plasma insulin was p40 pmol/l on more than two occasions (B67th percentile for nondiabetic subjects in our laboratory). 20 An elevated fasting plasma insulin concentration has been strongly correlated with insulin resistance measured by the HI clamp technique. 21 All procedures were reviewed and approved by the Human Subjects Review Committee, Ethics Review Office of the University of Toronto, and all subjects gave informed consent.
Study design
The study design was split-plot with 'crossed' preload (control and glucose drink) and 'nested' insulin status (NI and HI) effects (i.e. each subject changed preload but remained within the given insulin classification). The study was composed of two phases. The objective of phase 1 of this study was to measure mealtime energy intake after a glucose preload in HI and NI men. Subjects were given either a glucose or control treatment in random order. The glucose treatment contained 75 g of glucose (82.5 g of glucose monohydrate source) dissolved in 300 ml of cold spring water. The control treatment was matched for sweetness to the glucose treatment with 250 mg of sucralose, a noncaloric sweetener (McNeil Speciality Products Company, New Brunswick, NJ, USA). Sucralose was chosen because it does not affect carbohydrate metabolism, blood glucose or insulin secretion. 22 All test beverages were prepared 1 h before consumption, stored in a refrigerator, and was served chilled. Lemon concentrate (Equality; The Great Atlantic and Pacific Company of Canada LTD, Toronto, Canada) was added in to match for palatability. The objective of phase 2 of this study was to measure the response of plasma glucose, insulin, CCK, leptin and adiponectin to a glucose preload in HI and NI men. The glucose preload consisted of 75 g of glucose (82.5 g of glucose monohydrate) dissolved in 300 ml of cold spring water.
Protocol
Phase 1: food intake in response to glucose drink. Subjects chose a time between 0700 and 1000 to participate in the sessions, and they were asked to arrive at the same time for the subsequent session. There was a 1-week washout period between the two sessions. Subjects arrived at the study room in the Department of Nutritional Sciences at the University of Toronto for each session after an overnight fast (10-14 h). Water was allowed up to 1 h before the start of each session. On arrival, subjects completed baseline visual analogue scale (VAS) questionnaires measuring their motivation to eat, and then they were asked to proceed to a taste panel room where they consumed either the glucose treatment (82.5 g of glucose monohydrate, 5 ml lemon juice and water up to 300 ml) or the control treatment (250 mg of sucralose, 5 ml of lemon and water up to 300 ml) within 5 min. The two treatments were given in a random order. The subjects then returned to a study room and they completed VAS questions at 15, 30, 45 and 60 min after the preloads. Each page of the questionnaire was folded out of view after each rating. The subjects remained seated throughout the study period.
At 60 min after the glucose or control treatment, subjects returned to the taste panel room and were given 1.5 l of bottled spring water (Crystal Springs; Aquaterre Corp, St-Laurent, Canada) and an ad libitum pizza meal, and were instructed to eat until comfortably full. Before the sessions, the subjects ranked the pizza according to their preference. The participants were served two pizzas of their first choice and one each of their second and third choices per tray. Each pizza was cut into four quarters. The subjects were told that additional identical hot trays would be presented in 6-7 min. Four varieties of small round (5-inch diameter) Hyperinsulinemia, food intake and satiety hormones RA Samra et al pizzas (Deluxe, Pepperoni, Three Cheese and Deli Lovers; McCain Foods Ltd, Florenceville, Canada) purchased from local retailers were available. The amount of cooked pizza and water consumed was determined by the difference between the weight of the pizza and water before and after the subjects ate. An advantage of using these pizzas was the lack of an outer crust, which results in a pizza with uniform energy content and eliminates the possibility that the subject will eat the energy-denser filling and leave the outside crust of the pizza.
Each variety of pizza was weighed separately and the energy consumed was calculated by converting the net weight to kcal by use of information provided by the manufacturer (McCain). Water consumption was determined by weighing before and after the test meal. On termination of the test meal, the subjects rated the palatability of the test meal and completed the post-meal motivation-to-eat questionnaire. In addition, all subjects completed an Eating Habits Questionnaire to determine their eating restraint (ER) score. 23 The motivation-to-eat VAS questionnaire, used to assess appetite, was composed of four standardized questionnaires or scales: (1) How strong is your desire to eat? ('very weak' to 'very strong'), (2) How hungry do you feel? ('not hungry at all' to 'as hungry as I've ever felt'), (3) How full do you feel? ('not full at all' to 'very full'), and (4) How much food do you think you could eat? ('nothing at all' to 'a large amount'). Each VAS consisted of a 100-mm line anchored at the beginning and end by opposing statements. 24 The subjects marked an 'X' on the line to indicate their feelings at that given moment. Scores were determined by measuring the distance (in mm) from the left starting point of the line to the intersection of the 'X'. The palatability of the test meal was measured with a VAS. The question 'how pleasant have you found the food?' could be answered by marking on a 100-mm line anchored at the beginning and end by the statements 'not at all pleasant' and 'very pleasant.'
Phase 2: satiety hormone response to a glucose drink. On a separate day, both HI and NI subjects arrived between 0730 and 1000 at St Michael's Hospital where they consumed the 75 g glucose drink within 10 min after a 10-14 h overnight fast. Venous blood was obtained at fasting and 30, 60, 90 and 120 min after they started drinking the glucose solution for determining glucose, insulin, CCK, ghrelin, leptin and adiponectin. Statistical analysis Subjects' characteristics in HI and NI groups were compared using Student's t-test. Food intake and average appetite were analyzed by two-way analysis of variance (ANOVA) with preload (control and glucose drink), group (NI and HI), preload Â group interaction and subject identification (ID) number as the random variable. Tukey's post hoc test was performed to compare treatments when treatment effects were statistically significant. Plasma glucose, insulin, CCK, ghrelin, leptin and adiponectin response was analyzed by repeated measures analysis of covariance using Proc Mixed to test the effect of time and group. Both BMI and respective fasting concentrations of the blood parameters were included in the model as covariates to control for differences in these variables between subjects. Preliminary exploration of the data showed that the relationship between blood parameters and time is best described as curvilinear. To model this we added the factor time 2 (time Â time) to our model. This approach to modeling nonlinear relationships is often called polynomial or curvilinear regression. 26 The interaction of group and time was included in the model to assess whether the time of the blood variable peak was different between the groups, and the interaction of time 2 and group was included to test differences in the shape of the curves for NI and HI subjects. Subject was included in the model as a factor nested within group because subjects were not randomly assigned to the groups. Correlation analysis was conducted to evaluate the relation among dependent measures with the use of Pearson partial coefficients controlling for subjects.
Biochemical analyses
Net incremental area under the curves (AUC) for plasma glucose insulin, CCK, leptin and adiponectin response and net incremental area above the curve for plasma ghrelin response was calculated by applying the trapezoid rule. 27 The net AUC included all incremental area below the curve, including the area below fasting concentration. As net AUC is calculated by applying the trapezoid rule to both positive and negative blood glucose increments, the effect is to subtract the area below the fasting concentration from that above.
The magnitude of response at 60 min of each hormone was calculated by dividing the concentration of the hormone at 60 min with its concentration at 0 min (baseline).
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Average appetite score, a measure of the motivation-to-eat, was calculated at each time of measurement for each test beverage by the formula:
Appetite score ¼ fdesire to eat þ hunger þ ð100 À fullnessÞ þ prospective consumptiong=4 which reflected the four questions on the motivation-to-eat questionnaire. Statistical analysis was conducted using SPSS software (version 11.5; SPSS Inc., Chicago, IL, USA) and SAS software (version 9; Cary, NC, USA). All values are presented as means7standard error of the mean (s.e.) and Po0.05 indicates statistical significance.
Results
Subject characteristics HI subjects had a higher BMI, weight, waist circumference, fasting plasma triacylglycerols, LDL, total cholesterol/HDL ratio, glucose, insulin and leptin and a significantly lower plasma HDL and ghrelin than the NI subjects (Po0.05). However, age, height, ER score, fasting plasma total cholesterol, FFAs, CCK and adiponectin were not different between the two groups ( Table 1) .
Food intake
Analysis of food intake was adjusted for BMI to control for the difference in BMI between the HI and NI groups. After adjustment, food intake was reduced by the glucose preload (Po0.01) and by hyperinsulinemia (P ¼ 0.06), with no interaction between the effects of these main factors. Mean food intake reduction in response to the glucose drink was greatest in the HI men (Table 2) .
Average appetite Average appetite scores, expressed as the difference from baseline and adjusted for BMI, did not differ between the two groups. However, appetite changed over time (P ¼ 0.05). Post hoc analysis showed that at 15 min, the reduction in appetite score was greater after both the control and glucose treatments in NI than in HI men. Average appetite score was unchanged after the glucose treatment in the HI group, whereas the score was lower in the NI group at 15 min (Po0.05) (Figure 1 ). This means that the NI group had less motivation to eat at 15 min compared to the HI group. Average appetite did not differ between groups at the other times, and there was no statistically significant difference between average appetite scores AUC after control and glucose treatments in HI and NI groups.
Of the individual motivation-to-eat scores, only 'desire to eat' showed a treatment effect at 15 min (Po0.05). The increase in desire to eat was higher in the HI group than in the NI group after the glucose drink (Po0.05), consistent with the overall appetite score.
Palatability
No differences in subjective ratings of palatability for the pizza test meal were found between the HI and NI groups.
Plasma glucose, insulin, CCK, ghrelin, leptin and adiponectin To control for the effect of the differences between the two groups in BMI and fasting concentrations of the measures (Table 1) , these variables were included as covariates in the analysis of the effect of group and time on treatment responses. In addition, because the data for insulin, CCK and leptin were not normally distributed, the analysis was conducted on the log-transformed data (Table 3) . BMI was a significant predictor of the plasma CCK, ghrelin and leptin response to a glucose load. Similarly, fasting concentrations of insulin, glucose, ghrelin leptin and adiponectin affected their respective later response to a glucose load.
Plasma glucose increased with time (Po0.001) and was higher in the HI group than the NI (P ¼ 0.02) ( Table 3) . But AUC of plasma glucose was not significantly different between the HI and NI groups, and there was no significant group Â time and time 2 interactions, indicating that the Hyperinsulinemia, food intake and satiety hormones RA Samra et al plasma glucose response and shape of the curve were similar in HI and NI groups (Table 3) .
Plasma insulin concentration increased with time, and was higher in the HI group as also shown by the higher AUC compared to the NI group (Po0.0001) (Table 3, Figure 2 ). Both HI and NI groups showed a similar insulin response and curve shape over time (Figure 2) . Plasma CCK over time and the AUC for plasma CCK were higher in the HI group than the NI group (P ¼ 0.01) (Figure 2 ), but did not change over time (Table 3) .
Plasma ghrelin decreased with time and was lower in the HI group (P ¼ 0.01; Table 3, Figure 2 ). There was no time or time 2 Â group interaction; suggesting that the HI and NI groups showed a similar pattern of change and curve shapes with time (Table 3) , which was confirmed by the similar net AUC for the two groups ( Figure 2 ). Plasma leptin was higher in the HI group than the NI group (Po0.001), but did not change in response to the glucose preload ( Figure 3 ; Table 3 ). On the other hand, plasma adiponectin was lower in the HI group (P ¼ 0.01), and did not change after the glucose preload ( Figure 3 ; Table 3 ).
The magnitude of response to the glucose load up to 60 min showed plasma insulin to increase 10-fold in the HI group and 11-fold in the NI group (Table 4 ). This was followed by plasma CCK that increased by 2.1-fold in the HI group and was unchanged in the NI group. Plasma glucose increased by 1.6-and 1.7-fold in the NI and HI groups, respectively. Plasma ghrelin decreased by 0.8-fold in both HI and NI groups. Plasma adiponectin and leptin did not change from fasting to 60 min after the glucose load (Table 4) .
Correlations between food intake and other dependent variables Significant associations between food intake and dependent measures after the glucose preload were few and are Figure 1 Change in average appetite scores and net incremental AUC, measured by visual analogue scales, over 1 h in normoinsulinemic (NI) (n ¼ 33) subjects after a control preload ('), in NI subjects after a glucose preload (m), in hyperinsulinemic (HI) (n ¼ 32) subjects after a control preload (&), and HI subjects after a glucose preload (n). The two preloads were equalized for sweetness with the addition of the noncaloric sweetener sucralose, and all treatments were provided as isovolumetric (300 mL) beverages. An insulin status effect was observed at 15 min (Po0.05).
a Treatments with different letters are significantly different, Po0.05 (Tukey's adjustment). Hyperinsulinemia, food intake and satiety hormones RA Samra et al described below. Food intake correlated positively with ghrelin at 60 min (r ¼ 0.4, Po0.01) in the pooled data. However, this association was found within the NI group (r ¼ 0.64, Po0.001) and not the HI group. No statistically significant correlations were found between food intake and insulin, CCK, leptin and adiponectin responses in either the pooled data or within each group.
Correlations between plasma insulin and other dependent variables For all subjects, fasting plasma insulin correlated positively with BMI, waist circumference, total cholesterol/HDL ratio and leptin at 0, 60 and 120 min and negatively with fasting HDL and ghrelin (Table 5 ). In the NI group, fasting plasma insulin correlated positively with BMI, waist circumference, triacylglycerol, total cholesterol/HDL ratio and leptin at Hyperinsulinemia, food intake and satiety hormones RA Samra et al 60 min. In the HI group, fasting insulin correlated positively with waist circumference and plasma leptin at 0, 60 and 120 min (Table 5) .
Insulin AUC correlated positively with CCK AUC, BMI and fasting leptin and negatively with fasting adiponectin in the pooled sample (Table 5 ). In the NI group, insulin AUC correlated positively with CCK AUC (Table 5 ). In the HI group, insulin AUC correlated negatively with fasting adiponectin (Table 5) .
No significant associations were found among the hormones CCK, ghrelin, leptin and adiponectin in either of the groups or in the pooled data.
Correlations between BMI and plasma lipids Among the measured plasma lipids, BMI was significantly correlated with fasting plasma HDL (r ¼ À0.4, Po0.0001), plasma LDL (r ¼ 0.26, Po0.05) and ratio of total cholesterol/ HDL (r ¼ 0.38, Po0.001) in all subjects.
Discussion
This study provides physiologic support for the hypothesis that hyperinsulinemia provides a protective-adaptive response in food intake regulatory mechanisms leading to resistance to weight gain. 7 Hyperinsulinemia modifies and integrates the effect of carbohydrate on the short-term responses of several satiety hormones in a direction that would be predicted to contribute to resistance to weight gain through improved intake control. A statistically significant reduction in food intake averaging 90 kcal after the glucose load was seen only in the HI men ( Table 2 ). The lack of a statistically significant response in the NI men is in contrast to the more robust response of 150 kcal or more in young men consuming meal intakes of 1000 kcal. [15] [16] [17] In the present study, the subject participation was from the general population of Toronto recruited through newspaper ads and of a wider age and ethnic range than the young subjects primarily from the university environment used in previous studies. [15] [16] [17] Nevertheless, the suppression of food intake post-glucose preload was statistically significant for the HI men. Possibly, if the glucose load had been given on a body weight basis, the difference between the two groups would be greater because the HI group on average had a higher BMI.
Lower food intake in men consuming a glucose load compared with an energy-free control has been associated with an increase in blood glucose in normal 16 and type 2 diabetic subjects. 28 However, the results of the present study suggest that insulin, not glucose response, is a more likely mechanistic explanation. The greater postprandial reduction in mealtime food intake of the HI men occurred in association with a similar blood glucose response to that of the NI men (Figure 2 ), but is consistent with the role of insulin in both long-and short-term regulation of food intake. [29] [30] The primary role for insulin in intake regulation is supported by several lines of evidence. Chronic hyperinsulinemia alone contributes to insulin's long-term regulatory role through increased insulin concentration in the hypothalamus. 31 In rats and baboons, increasing insulin in the brain by infusion into either the lateral or third ventricle of the hypothalamus results in dose-dependent decreases in food intake. 32, 33 In the short term, in NI individuals, high plasma insulin in response to carbohydrate foods is also associated with reduced food intake at a later meal. [3] [4] [5] Furthermore, the greater importance of insulin compared to glucose in short-term intake regulation is illustrated by the observation that decreased food intake occurs in euglycemic HI rats 34 Hyperinsulinemia, food intake and satiety hormones RA Samra et al
In addition to the objective of describing the relationship between HI and food intake after a glucose preload, other hormones involved in food intake regulation were measured for two reasons. First, the physiological regulation of food intake is based on a complex array of responses, 8 and their hierarchy in determining satiety in either HI or NI individuals remains to be determined. Second, few studies report concurrent responses in more than one or two hormones. In general, both fasting and post-glucose response in the satiety hormones were consistent with a physiological explanation for the greater reduction in food intake in the HI men. Similar to the literature, the HI men had lower fasting ghrelin 14 and adiponectin, 37 and increased leptin.
38
Compared with the NI men, the postprandial response to the glucose load was higher for insulin, CCK, leptin, and was lower for ghrelin in the HI men (Table 3 ). All these responses would be expected to favor reduced food intake 1 h later. Evidence for a primary role for insulin in directing satiety hormone responses, as previously suggested, 8 is provided by the present study. This role is demonstrated in two ways. First, the magnitude of response in plasma insulin after a glucose load was highest (fivefold) compared to the other satiety hormones (Table 4) , and second, by the statistically significant associations of fasting blood concentrations of insulin with fasting concentration of ghrelin and leptin, and of the AUC for insulin and CCK after the glucose drink (Table 5) . In contrast to their association with insulin, there were no associations found among CCK, ghrelin and leptin either at fasting or postprandially. Other reports also suggest that insulin directs satiety hormone responses, but there is limited data in humans. Insulin infusions to the hypothalamus of rats result in increased CCK sensitivity, 29 and insulin given intravenously results in higher plasma leptin in humans 39 and lower plasma ghrelin in rats 40 and humans. 41, 42 A carbohydrate-mediated increase in plasma CCK concentrations 43 and a decrease in plasma ghrelin 44 have been reported in NI individuals. Plasma leptin did not respond to the glucose load consistent with the evidence that systemic leptin concentration is not affected by short-term food intake. 18 The inverse correlation between insulin and adiponectin is consistent with hyperinsulinemia as a determinant of hypoadiponectinemia in obesity and type 2 diabetes. 37, 45, 46 The lack of response in plasma adiponectin to the glucose load supports the view that it is not involved in short-term food intake regulation, but is primarily an adipostat regulating energy balance. 46 The relatively few statistically significant correlations between hormonal and glucose responses with food intake and appetite scores are probably because the blood samples obtained for metabolic measurements were obtained on a different day from the feeding studies. This was done because of uncertainty of the effect of an indwelling catheter and frequent blood sampling on appetite and food intake. In a recent study, we found that blood sampling with intravenous indwelling catheter resulted in 10% lower food intake at a test meal compared to when blood samples were obtained by finger prick (T Akhavan, unpublished data). However, others have found that when feeding and metabolic studies were done on the same day, subjective appetite was associated with plasma glucose, insulin and ghrelin concentrations. 47 In NI men, a decrease in both appetite score and food intake after carbohydrate consumption is often found. 15, 16 In this study, the HI men decreased food intake but did not express the same decrease in appetite score as the NI men 15 min after the glucose preload. The failure to decrease appetite may be a consequence of hyperinsulinemia although this is not clear, because hyperinsulinemia induced by intravenous infusions under euglycemic conditions has been reported to result in either increased hunger 48 or no effect on sensations of appetite 49, 50 in healthy subjects. However, appetite ratings
were not different between groups at 60 min, when subjects consumed the ad libitum meal and food intake was different. This is not surprising because the subjective measure of appetite is often found not to be predictive of food intake. For example, differences in ad libitum food intake between treatments have been observed previously with no reported effect of treatments on appetite. 51 Unfortunately, the HI and NI subjects differed in many baseline characteristics including BMI and fasting plasma lipids and cholesterol in the present study (Table 1) as this study was originally designed to answer a different question. 20 Therefore, to remove the influence of BMI, a covariate analysis was run with only BMI included in the model for the following two reasons. First, BMI and plasma lipids and cholesterol are correlated and cannot be included together in the model owing to collinearity. Second, BMI is associated with food intake, 52, 53 but there is no evidence relating fasting plasma lipids and cholesterol to short-term food intake.
To establish that HI is a protective adaptive response contributing to weight stability, future studies would need to compare HI and NI individuals at similar BMI and baseline characteristics. Also concurrent measurement of food intake and hormone responses would be useful. However, the present study provides support for the proposal that the goal of achieving weight loss and improved metabolic control through energy restriction will lead to changes in appetite control that may be difficult in long-term maintenance of reduced body weight.
In summary, hyperinsulinemia was found to improve food intake compensation in association with elevated fasting concentrations of insulin and leptin, and with higher postprandial insulin, glucose, CCK, leptin and lower ghrelin concentrations.
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